JP2010539490A5 - - Google Patents

Download PDF

Info

Publication number
JP2010539490A5
JP2010539490A5 JP2010525032A JP2010525032A JP2010539490A5 JP 2010539490 A5 JP2010539490 A5 JP 2010539490A5 JP 2010525032 A JP2010525032 A JP 2010525032A JP 2010525032 A JP2010525032 A JP 2010525032A JP 2010539490 A5 JP2010539490 A5 JP 2010539490A5
Authority
JP
Japan
Prior art keywords
biomarkers
results
obtaining
alternative
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010525032A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010539490A (ja
Filing date
Publication date
Priority claimed from US12/034,698 external-priority patent/US20090075266A1/en
Application filed filed Critical
Publication of JP2010539490A publication Critical patent/JP2010539490A/ja
Publication of JP2010539490A5 publication Critical patent/JP2010539490A5/ja
Pending legal-status Critical Current

Links

JP2010525032A 2007-09-14 2008-09-12 多数の分析物の診断読み出し情報 Pending JP2010539490A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97250707P 2007-09-14 2007-09-14
US12/034,698 US20090075266A1 (en) 2007-09-14 2008-02-21 Multiple analyte diagnostic readout
PCT/US2008/076193 WO2009036288A1 (en) 2007-09-14 2008-09-12 Multiple analyte diagnostic readout

Publications (2)

Publication Number Publication Date
JP2010539490A JP2010539490A (ja) 2010-12-16
JP2010539490A5 true JP2010539490A5 (enExample) 2011-10-20

Family

ID=40452512

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010525032A Pending JP2010539490A (ja) 2007-09-14 2008-09-12 多数の分析物の診断読み出し情報

Country Status (6)

Country Link
US (1) US20090075266A1 (enExample)
EP (1) EP2198295A4 (enExample)
JP (1) JP2010539490A (enExample)
CN (1) CN101878426A (enExample)
CA (1) CA2698859A1 (enExample)
WO (1) WO2009036288A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090047694A1 (en) * 2007-08-17 2009-02-19 Shuber Anthony P Clinical Intervention Directed Diagnostic Methods
JP2010524003A (ja) * 2007-04-13 2010-07-15 ブリストル−マイヤーズ スクイブ カンパニー 血管内皮増殖因子受容体−２モジュレーターに対する感受性を決定するためのバイオマーカーおよび方法
US20090029372A1 (en) * 2007-05-14 2009-01-29 Kobenhavns Universitet Adam12 as a biomarker for bladder cancer
US8431367B2 (en) 2007-09-14 2013-04-30 Predictive Biosciences Corporation Detection of nucleic acids and proteins
US20100267041A1 (en) * 2007-09-14 2010-10-21 Predictive Biosciences, Inc. Serial analysis of biomarkers for disease diagnosis
US7955822B2 (en) * 2007-09-14 2011-06-07 Predictive Biosciences Corp. Detection of nucleic acids and proteins
US20120053079A1 (en) * 2009-03-06 2012-03-01 University Of South Alabama Methods and compositions for the diagnosis, prognosis and treatment of cancer
JP5451552B2 (ja) * 2010-08-09 2014-03-26 オリンパス株式会社 顕微鏡システム、標本観察方法およびプログラム
ES2656150T3 (es) 2011-11-14 2018-02-23 Universitätsklinikum Jena Diagnóstico de la sepsis y del síndrome de respuesta inflamatoria sistémica
WO2014191936A1 (en) * 2013-05-29 2014-12-04 Institut National De La Sante Et De La Recherche Medicale Kir3dl2 is a biomarker and a therapeutic target useful for respectively preventing and treating a subset of cutaneous and non-cutaneous peripheral t-cell lymphomas
JP6250351B2 (ja) * 2013-09-30 2017-12-20 シスメックス株式会社 好酸球性気道炎症に関する情報の取得方法およびそのような情報を取得するためのマーカー
BR112018067292A2 (pt) * 2016-03-02 2019-01-02 Idexx Lab Inc métodos e composições para a detecção e o diagnóstico de doença renal e doença periodontal
US20180299445A1 (en) * 2017-04-03 2018-10-18 Biodetego Llc Biomarkers and methods of using same
GB201810571D0 (en) * 2018-06-27 2018-08-15 Cs Genetics Ltd Reagents and methods for the analysis of circulating microparticles
US20210325380A1 (en) * 2020-04-20 2021-10-21 EnLiSense, LLC Disease diagnostics using a multi-configurable sensing array
CN116930498B (zh) * 2023-08-29 2023-12-12 中国人民解放军军事科学院军事医学研究院 一种原发性肝细胞癌切除术后复发风险预测试剂盒及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324634A (en) * 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
US6566101B1 (en) * 1997-06-16 2003-05-20 Anthony P. Shuber Primer extension methods for detecting nucleic acids
US20040219509A1 (en) * 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
JP3771502B2 (ja) * 2002-02-14 2006-04-26 国立大学法人 新潟大学 精神分裂病により発現量が変化する遺伝子を規定する核酸を解析する方法
EP1587955A4 (en) * 2002-12-24 2007-03-14 Biosite Inc DIFFERENTIAL DIAGNOSTIC MARKERS AND METHODS OF USE
EP2026071B1 (en) * 2004-02-19 2013-07-31 Yale University Identification of cancer protein biomarkers using proteomic techniques
BRPI0607753A2 (pt) * 2005-02-16 2009-10-06 Wyeth Corp método para prever um efeito clìnico em resposta a um tratamento de uma leucemia; método para prever um efeito clìnico de uma leucemia; método para selecionar um tratamento para um paciente com leucemia; método para o diagnóstico ou monitoramento de ocorrência, desenvolvimento, progressão ou tratamento de uma leucemia; arranjo para uso num método para prever um efeito clìnico para um paciente aml; arranjo para uso num método de diagnóstico de aml; meio legìvel por computador; kit para o prognóstico de aml
WO2006089087A2 (en) * 2005-02-17 2006-08-24 Dana-Farber Cancer Institute, Inc. Compositions, kits and methods for identification, assessment, prevention and therapy of cancer
JP2008538007A (ja) * 2005-04-15 2008-10-02 ベクトン，ディッキンソン アンド カンパニー 敗血症の診断
US20070099239A1 (en) * 2005-06-24 2007-05-03 Raymond Tabibiazar Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease
WO2007050706A2 (en) * 2005-10-27 2007-05-03 University Of Missouri-Columbia Dna methylation biomarkers in lymphoid and hematopoietic malignancies
ES2606015T3 (es) * 2005-12-22 2017-03-17 Abbott Molecular Inc. Métodos y combinaciones de marcadores para la detección de la predisposición al cáncer de pulmón
US9347945B2 (en) * 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
US20070255113A1 (en) * 2006-05-01 2007-11-01 Grimes F R Methods and apparatus for identifying disease status using biomarkers
US20090047694A1 (en) * 2007-08-17 2009-02-19 Shuber Anthony P Clinical Intervention Directed Diagnostic Methods

Similar Documents

Publication Publication Date Title
JP2010539490A5 (enExample)
CN107849610B (zh) 早期阿尔茨海默病或轻度认知障碍诊断方法
JP5311439B2 (ja) 皮膚の状態を評価する方法及びその用途
JP2011516046A5 (enExample)
JP2018537128A5 (enExample)
JP5916130B2 (ja) 病気の重症度の検査方法
TWI670495B (zh) 一種鑑定樣本中腫瘤負荷的方法和系統
DE60207979D1 (de) Verfahren und Vorrichtung zur Bestimmung der Gewebespezifität von freier DNA in Körperflüssigkeiten
WO2015079060A2 (en) Mirnas as advanced diagnostic tool in patients with cardiovascular disease, in particular acute myocardial infarction (ami)
EP3772066A3 (en) Biological status classification
EP3764877A1 (en) Assessing transplant rejection status by analysis of t-cell receptor subunit repertoire diversity
CN110320184A (zh) 基于对皮肤和指甲角蛋白的检测判断帕金森病的方法及其应用
CN112813159A (zh) 帕金森病的生物标志物及其应用
JP2022097301A (ja) ストレスマーカー及びそれを用いた慢性ストレスレベルの検出方法
US20200263249A1 (en) Method and Kit for Predicting Susceptibility to Allergic Reaction
CN112921079A (zh) 一种基于microRNA的早期肝纤维化诊断标志物及试剂盒
JP2003038198A (ja) 精神分裂病により発現量が変化する遺伝子を規定する核酸を解析する方法
CA2971993C (en) Methods for diagnosing chronic valvular disease
EP4409043B1 (en) Faecal microbiota signature for pancreatic cancer
CN119410777B (zh) 一种胶质瘤诊断、复发监测或预后评估的基因标志物组合及其应用
JP7655721B2 (ja) 疲労マーカー及びそれを用いた疲労の検出方法
CN110161251A (zh) 基于指甲外的角蛋白片段和角蛋白水平作为生物标记物在制备用于诊断肺癌的产品中的应用
EP2730922A1 (en) Method and system for detecting lymphosarcoma in cats using biomarkers
KR20250079914A (ko) 암 사전 선별을 위한 바이오마커 기반 평가에 임상적 위험 요소 통합
RU2016137444A (ru) Способ ранней доклинической диагностики болезни Паркинсона на основе анализа биомаркеров в крови у больных и на экспериментальных моделях ранней клинической и доклинической стадий этого заболевания